1. Market Research
  2. > Healthcare Market Trends
  3. > Google’s Ambitions in Health

Google’s Ambitions in Health

  • January 2015
  • -
  • Firstword Pharma
  • -
  • 54 pages




The idea barely existed five years ago, but it certainly does now. Digital healthcare technology has arrived—and it’s getting plenty of attention. In a year when US venture capital funding hit its highest point since 2001, with $47.3 billion, healthcare funding in 2014 dominated the technology space.

In Google's Ambitions in Health, FirstWord maps the journey of one of the leading technology companies and provides context and insights about other companies also investing in the rapidly evolving field of healthcare technology.

Based on expert interviews, market analysis and up-to-date news and views from the field, the report tracks current moves and strategies of leading healthcare tech giants. Focused on Google, and including insights on Apple, Microsoft and others, this report analyses key partnerships and offers insight into pharma’s future in one of the most dynamic and fast-evolving industries.

As digital healthcare technology finds new and innovative ways to put healthcare into the hands of consumers, key questions remain: what might pharma lose by not getting involved in health technology, and where does pharma go from here?







Key Takeaways

Insight into the strategies behind Google’s foray into digital healthcare
First hand analysis of how Google is carving out a dominant position in health data and analytics
Timely expert views on pharma’s role as an enabler of health data and systems integration and data sharing
Breakdown of Google’s key health ventures, including the Calico/AbbVie partnership
Access expert knowledge of how pharma can ‘co-create’ the future of digital healthcare

Answers to Pressing Questions

What does 2015 hold when it comes to ‘co-creating’ healthcare through new partnerships and unconventional alliances?
With consumers gaining access to sophisticated diagnostics such as genomics sequencing and wearable devices, what is the future of DIY health?
As tech companies increasingly invest in healthcare, where will opportunities arise for pharma? And more importantly, what’s at risk if pharma doesn’t embrace this digital revolution?
Where else is Google focusing its energy in healthcare?
If Google plans to innovate without a concern for profit, how will this impact pharma?


Report Features

In-depth expert interviews and research covering the consumerisation of healthcare
Four key strategies for building smart digital healthcare partnerships
Analysis of Google’s key digital healthcare ventures and where they’re headed, plus insights into Apple’s ambitions in the space
Assessments of Google’s European and US investments and ventures
Expert insight into DIY Health and its future


Expert Contributors

Chief Medical Officer, mobile health solutions company
Trauma Surgeon/Google Glass Explorer, Medical Center, US
CEO at a drug development company, US
Director at center for innovation at an EU university
Director at an leading pharmaceutical company
Head of Epidemiology at a biotech company in France
Digital Marketing Manager at a global pharmaceutical company
Executive Vice President at a pharmaceutical marketing agency
Development manager at a pharmaceutical marketing agency
Director of Product Marketing at a clinical research company
Chief of Staff at a clinical research company
Senior Director of Product at a clinical research company




About FirstWord Reports



FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.

FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. FirstWord Reports provide expert views and intelligence on the challenges facing pharma today in these topic areas: Biosimilars, Market Access, Medical Affairs, Sales & Marketing, Technology, Therapy Areas.
FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.

Learn more at www.firstwordgroup.com.


Table Of Contents

Google’s Ambitions in Health
1.Executive summary
2.Methodology and objectives
3.Digital health tech is booming
3.1.Venture capital funding and healthcare IPOs
3.2.$4.1 billion in US digital health funding
3.3.Digital health funding in Europe
3.4.Map of digital health startups in Europe

4.Tech giants in healthcare
4.1.Is the interest of tech giants in healthcare a fad or long-term trend?
4.2.onsumerisation of healthcare
4.3.DIY Health
4.4.Outside expertise brings opportunities for pharma
4.5.What are the opportunities for pharma from this change?

5.Google Ventures quadruples health investments
5.1.Google Ventures invests in Europe
5.2.Google Ventures portfolio

6.Google Ventures capitalises on health data and analytics
6.1.Flatiron Health: largest Google Ventures investment
6.2.GV companies share valuable data for pharma research
6,3,23andMe inks data deals with Genentech, Pfizer, and more
6.4.Foundation Medicine nets $1 billion deal with Roche
6.5.Google X partners with Biogen Idec in multiple sclerosis
6.6.Data sharing deals with pharma raise privacy concerns
6.7.Open APIs and sharing data
6.8.Are there opportunities for pharma in open APIs and sharing data?
6.9.FDA draft guidance for general wellness or low risk devices

7.Google Calico: a separate life sciences company
7.1.Google X Life Sciences Division separate from Calico
7.2.Calico's partnership with AbbVie
7.3.What are the thoughts on the research Google is doing in life sciences with
7.4.Calico, and its partnership with AbbVie?

8.Google Glass and other health interests
8.1.Google looks to innovate without a concern for profits in the near term.
8.2.Will this be disruptive to pharma?
8.3.Going fast and going slow: speed of innovation
8.4.The tech industry is known for its speed of innovation, and pharma is
traditionally slow. What are the challenges in partnering?

9.Apple's health app and the HealthKit platform
9.1.What opportunities do you see from Apple HealthKit?
10.Digital Therapeutics: services versus products
10.1.How will new technologies help pharma provide services as opposed to products?
10.2D.o you see pharma developing Digital Therapeutics?
11. Co-creating the future of health
11.1.The keys to building successful partnerships
11.2.A successful alliance: Salesforce and Philips
11.3.Patients at the centre
11.4.What are the keys for a successful partnership between pharma and
technology companies?
11.5.How do you envision the pharma model changing?
12.Conclusion

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.